Unveiling Cardiac Amyloidosis: A Case Report Exploring The Role of Multimodal Imaging

  • Yosua Cristo Reynaldo Napitupulu Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Hilfan Ade Putra Lubis Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Cut Aryfa Andra Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Anggia Chairuddin Lubis Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Keywords: Amyloidosis, Heart Failure, Infiltrative disease, CMR

Abstract

Background: Cardiac Amyloidosis (CA) is a condition caused by the deposition of amyloid fibrils in the heart. The diagnosis of CA can be challenging and requires a high index of suspicion. Multimodality imaging, including echocardiography and Cardiac Magnetic Resonance (CMR), plays a crucial role in the diagnosis, evaluation, and management of CA. This case report presents a patient with suspected CA and highlights the role of multimodality imaging in diagnosis.

Case Illustrations: A 49-year-old male with previously diagnosed hypertension came with progressive dyspnea, fatigue, and lower extremity edema. Initial clinical suspicion for Heart Failure with preserved Ejection Fraction (HFpEF) with increased thickness in the Interventricular Septum (IVS) was raised. Electrocardiography showed Left Ventricular Hypertrophy (LVH). Further diagnostic work-up revealed evidence of CA. Both multimodal imaging, including echocardiography and cardiac Magnetic Resonance Imaging (MRI), were used to confirm the diagnosis.

The patient underwent comprehensive multimodal imaging, which included: 1) Echocardiography showed LVH with diastolic dysfunction (E’ <5), myocardial sparkling, and cherry on top appearance in Global Longitudinal Strain (GLS) analysis with reduced GLS, suggestive of amyloid infiltration; 2) Cardiac MRI demonstrated diffuse subendocardial Late Gadolinium Enhancement (LGE) patterns typical of amyloid deposition.

The combination of imaging findings led to the diagnosis of CA. There was no Endomyocardial Biopsy (EMB) needed to reveal amyloid deposits. The patient was started on symptomatic management for heart failure.

Conclusion: This case highlights the importance of multimodality imaging in the diagnosis of CA. Echocardiography, CMR, and nuclear imaging are complementary tools that enhance diagnostic accuracy and guide treatment decisions. Early recognition of CA is crucial for appropriate management and better prognosis.

Downloads

Download data is not yet available.

Author Biographies

Hilfan Ade Putra Lubis, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan Indonesia

Cut Aryfa Andra, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan Indonesia

Anggia Chairuddin Lubis, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan Indonesia
Head of Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan Indonesia

References

1. Arbelo, E. et al. (2023) ‘2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)’, European Heart Journal, 44(37), pp. 3503–3626.
2. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021 Apr 21;42(16):1554-1568. doi: 10.1093/eurheartj/ehab072. PMID: 33825853; PMCID: PMC8060056.
3. Dorbala S., Cuddy S., Falk,R., How to Image Cardiac Amyloidosis. JACC: CARDIOVASCULAR IMAGING, VOL. 13, NO. 6, 2020.1369. JUNE 2020:1368–83. doi: 10.1016/j.jcmg.2019.07.015.
4. Kittleson MM, Maurer MS, Ambardekar AV. Cardiac amyloidosis: evolving diagnosis. Circulation. 2020.
5. Phelan D, et al. Apical sparing of longitudinal strain in cardiac amyloidosis. JACC Imaging. 2012.
6. Dorbala S., Ando Y., Bokhasi S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2021;14:e000029. DOI: 10.1161/HCI.0000000000000029.
7. Dungu JN., Valencia O., Pinney J.H., et al. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC: CARDIOVASCULAR IMAGING, VOL. 7, NO. 2, 2014. http://dx.doi.org/10.1016/j.jcmg.2013.08.015
8. Gillmore, J.D., Maurer, MS., Falk, RH., et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
9. Sanchez AC., Murphy R.m Rao S., et al. A Case Report of Cardiac Amyloidosis Highlighting the Importance of Strain Analysis. Hindawi Case Reports in Cardiology. Volume 2021, Article ID 5673364, 5 pages. https://doi.org/10.1155/2021/5673364
Published
2026-09-08
Views & Downloads
Abstract views: 50   
PDF downloads: 37   
How to Cite
Napitupulu, Y., Lubis, H., Andra, C., & Lubis, A. (2026). Unveiling Cardiac Amyloidosis: A Case Report Exploring The Role of Multimodal Imaging. Indonesian Journal of Cardiology. https://doi.org/10.30701/ijc.2076
Section
Case Reports